Position in GILD
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$497,526
+$59,905 QoQ
Shares Held
3,938
+25.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#1,374
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EWA, LLC holds $7,685,441 across 8 Drug Manufacturers - General names. GILD ranks #6 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,662 | $3,192,882 | |
| 2 | JNJ |
Johnson & Johnson
|
4,511 | $1,145,658 | |
| 3 | ABBV |
AbbVie Inc.
|
3,645 | $917,227 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,403 | $565,785 | |
| 5 | AZN |
Astrazeneca PLC
|
2,740 | $519,558 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
3,938 | $497,526 | |
| 7 | NVS |
Novartis AG
|
2,790 | $437,248 | |
| 8 | AMGN |
Amgen Inc
|
1,131 | $409,557 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $497,526 | 3,938 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $437,621 | 3,140 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $346,126 | 2,820 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $315,351 | 2,841 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $305,003 | 2,751 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $355,646 | 3,174 | Shares | Sole | 2025-04-22 | |
| No filing history on record for this holder in this stock. | ||||||